Entering text into the input field will update the search result below

Sanofi in multi-billion-dollar deal with Adagene for immuno-oncology candidates

Mar. 02, 2022 6:58 AM ETAdagene Inc. (ADAG) Stock, SNY StockMRKBy: Dulan Lokuwithana, SA News Editor2 Comments

Gratitude Concept With Heart Symbol

Eoneren/E+ via Getty Images

The ADRs of Adagene (NASDAQ:ADAG) have climbed ~17% in the pre-market Wednesday after the China-based clinical-stage biopharmaceutical company announced a partnership with Frech pharma giant Sanofi (NASDAQ:SNY) for the development and commercialization of certain immuno-oncology drugs.


Recommended For You

Comments (2)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

pat45 profile picture
ONLY $17.5 MILL IS NOW...BUT still good
misleading headline...all the 'billions' are biobucks...very early stage

Related Stocks

SymbolLast Price% Chg
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.